Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1 [Yahoo! Finance]
Janus Henderson Group plc Ordinary Shares (JHG)
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am
Check Earnings Report
US:NYSE Investor Relations:
snl.com/irw/corporateprofile/4147331
Company Research
Source: Yahoo! Finance
Jay Hagan joins as Chief Executive Officer leading a seasoned late-stage development team and will serve on the Board alongside Co-Founder and Chairman Keith Katkin Oversubscribed Series A financing co-led by RA Capital Management and Patient Square Capital's platform Enavate Sciences with participation from a strong syndicate of dedicated life sciences investors IRVINE, Calif. Dec. 16, 2025 /PRNewswire/ -- Ambros Therapeutics, Inc. today announced its launch as a clinical-stage biotechnology company advancing late-stage therapies for severe, underserved diseases beginning with neridronate for Complex Regional Pain Syndrome Type 1 (CRPS-1). Ambros launches with an oversubscribed $125 million Series A financing co-led by RA Capital Management and Patient Square Capital's platform Enavate Sciences, joined by Abiogen Pharma, Janus Henderson Investors, Arkin Bio, Balyasny Asset Management, Transhuman Capital, Adage Capital Partners LP, and other dedicated life sciences investors. T
Show less
Read more
Impact Snapshot
Event Time:
JHG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JHG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JHG alerts
High impacting Janus Henderson Group plc Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JHG
News
- Victory Park Capital Announces New Warehouse Facility with Zip, Expanding Long-Standing Partnership [Yahoo! Finance]Yahoo! Finance
- Guardian announces $1.7 billion dividend allocation [Yahoo! Finance]Yahoo! Finance
- Janus Henderson Group (NYSE:JHG) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- Former Amazon Studios boss warns the Netflix-Warner Bros. deal will make Hollywood ‘a system that circles a single sun' [Fortune]Fortune
- JAAA: Deciphering The Management Commentary [Seeking Alpha]Seeking Alpha
JHG
Earnings
- 10/30/25 - Beat
JHG
Sec Filings
- 12/3/25 - Form 4
- 11/14/25 - Form 13F-HR
- 10/30/25 - Form 10-Q
- JHG's page on the SEC website